{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:10:36Z","timestamp":1788246636670,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11882-016-0636-3","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T08:30:55Z","timestamp":1469521855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Botulinum Toxin for Rhinitis"],"prefix":"10.1007","volume":"16","author":[{"given":"Cengiz","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ismi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"issue":"suppl 86","key":"636_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen. Allergy. 2008;63 suppl 86:8\u2013160. This report is about updating the new classification of allergic rhinitis.","journal-title":"Allergy"},{"issue":"Suppl. 19","key":"636_CR2","first-page":"1","volume":"49","author":"International Consensus Report on Diagnosis and Management of Rhinitis","year":"1994","unstructured":"International Consensus Report on Diagnosis and Management of Rhinitis. International Rhinitis Management Working Group. Allergy. 1994;49 Suppl 19:1\u201334.","journal-title":"Allergy"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjoto.2006.01.008","volume":"27","author":"C Ozcan","year":"2006","unstructured":"Ozcan C, Vayisoglu Y, Dogu O, Gorur K. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol. 2006;27:314\u20138.","journal-title":"Am J Otolaryngol"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1746-160X-5-18","volume":"5","author":"S Rohrbach","year":"2009","unstructured":"Rohrbach S, Junghans K, K\u00f6hler S, Laskawi R. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med. 2009;5:18. This study is the first clinical study presenting the effect of sponge-soaked application of botulinum toxin-A.","journal-title":"Head Face Med"},{"issue":"Suppl 76","key":"636_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0108-1675.2004.00389.x","volume":"59","author":"C Bachert","year":"2004","unstructured":"Bachert C. Persistent rhinitis\u2014allergic or nonallergic? Allergy. 2004;59 Suppl 76:11\u20135. This review outlines how to differentiate allergic rhinitis from the non-allergic rhinitis and what is important to diagnose non-allergic rhinitis.","journal-title":"Allergy"},{"key":"636_CR6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0194-59989570289-X","volume":"112","author":"CM Shaari","year":"1995","unstructured":"Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg. 1995;112:566\u201371. This experimental study firstly showed the effect of BTX-A on nasal secretion.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"Suppl 3","key":"636_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2222.1996.tb00656.x","volume":"26","author":"JG Widdicombe","year":"1996","unstructured":"Widdicombe JG. Neuroregulation of the nose and bronchi. Clin Exp Allergy. 1996;26 Suppl 3:32\u20135.","journal-title":"Clin Exp Allergy"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5152\/balkanmedj.2015.151028","volume":"32","author":"O Ismi","year":"2015","unstructured":"Ismi O, Ozcan C, Karabacak T, et al. Local of neurotrophin-3 in neuronal inflammation of allergic rhinitis: preliminary report. Balk Med J. 2015;32:364\u201370.","journal-title":"Balk Med J"},{"key":"636_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11882-003-0042-5","volume":"3","author":"CF Tai","year":"2003","unstructured":"Tai CF, Baraniuk JM. A tale of two neurons in the upper airways: pain versus itch. Curr Allergy Asthma Rep. 2003;3:215\u201320.","journal-title":"Curr Allergy Asthma Rep"},{"key":"636_CR10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bjps.2008.03.023","volume":"61","author":"TA Laing","year":"2008","unstructured":"Laing TA, Laing ME, O\u2019Sullivan ST. Botulinum toxin for treatment of glandular hypersecretory disorders. J Plast Reconstr Aesthet Surg. 2008;61:1024\u20138.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"636_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxicon.2015.08.001","volume":"107","author":"AR Bentivoglio","year":"2015","unstructured":"Bentivoglio AR, Del Grande A, Perracca M, Ialonga T. Clinical differences between botulinum neurotoxin type A and B. Toxicon. 2015;107:77\u201384.","journal-title":"Toxicon"},{"key":"636_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.toxicon.2012.11.011","volume":"67","author":"AP Tighe","year":"2013","unstructured":"Tighe AP, Schiavo G. Botulinum neurotoxins: mechanism of action. Toxicon. 2013;67:87\u201393.","journal-title":"Toxicon"},{"issue":"suppl 8","key":"636_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mds.20067","volume":"19","author":"M Naumann","year":"2004","unstructured":"Naumann M, Jost W. Botulinum toxin treatment of secretory disorders. Mov Disord. 2004;19 suppl 8:137\u201341.","journal-title":"Mov Disord"},{"key":"636_CR14","first-page":"10","volume":"4","author":"R Persaud","year":"2013","unstructured":"Persaud R, Garas G, Silva S, Stamatoglou C, Chatrath P, Patel K. An evidence-based review of botulinum toxin (Botox) applications in non-cosmetic head and neck conditions. J R Soc Med Sh Rep. 2013;4:10.","journal-title":"J R Soc Med Sh Rep"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2012.10.020","volume":"67","author":"M Naumann","year":"2013","unstructured":"Naumann M, Dressler D, Hallett M, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013;67:141\u201352.","journal-title":"Toxicon"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-160X-4-5","volume":"4","author":"R Laskawi","year":"2008","unstructured":"Laskawi R. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med. 2008;4:5.","journal-title":"Head Face Med"},{"key":"636_CR17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000107422","volume":"14","author":"WD Wen","year":"2007","unstructured":"Wen WD, Yuan F, Wang JL, Hou YP. Botulinum toxin therapy in the ovalbumin-sensitized rat. Neuroimmunomodulation. 2007;14:78\u201383.","journal-title":"Neuroimmunomodulation"},{"key":"636_CR18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S0022215100158281","volume":"112","author":"KS Kim","year":"1998","unstructured":"Kim KS, Kim SS, Yoon JH, Han JW. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol. 1998;112:248\u201351.","journal-title":"J Laryngol Otol"},{"key":"636_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2009.12.989","volume":"125","author":"MS Dykewicz","year":"2010","unstructured":"Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125:103\u201315.","journal-title":"J Allergy Clin Immunol"},{"key":"636_CR20","doi-asserted-by":"crossref","unstructured":"Aoishi K, Takahashi H, Hato N, et al. Treatment of allergic rhinitis with intranasal infusion of botulinum toxin type A in mice. 2016; 147:132-6.","DOI":"10.1016\/j.lfs.2015.08.003"},{"key":"636_CR21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/000348940111001110","volume":"110","author":"S Rohrbach","year":"2001","unstructured":"Rohrbach S, Olthoff A, Laskawi R, Giefer B, G\u00f6tz W. Botulinum toxin type A induces apoptosis in glands of guinea pigs. Ann Otol Rhinol Laryngol. 2001;110:1045\u201350. This experimental study is the first study showing histological changes especially apoptosis of nasal glands after intranasal botulinum toxin application.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijporl.2016.01.010","volume":"83","author":"MS Gunes","year":"2016","unstructured":"Gunes MS, Kulahli I, Kokoglu K, et al. Evaluation of the effect of intranasal infiltrated botulinum toxin-A on a model of allergic rhinitis in rabbits: an experimental study. Int J Pediatr Otorhinolaryngol. 2016;83:51\u20136.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"636_CR23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2500\/ajra.2012.26.3785","volume":"26","author":"Z Zhu","year":"2012","unstructured":"Zhu Z, Stone HF, Thach TQ, Garcia L, Ruegg CL. A novel botulinum neurotoxin topical gel: treatment of allergic rhinitis in rats and comparative safety profile. Am J Rhinol Allergy. 2012;26:450\u20134.","journal-title":"Am J Rhinol Allergy"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000055778","volume":"63","author":"S Rohrbach","year":"2001","unstructured":"Rohrbach S, Laskawi R. Minimally invasive application of Botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec. 2001;63:382\u20134.","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"636_CR25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/00016489.2003.11720744","volume":"123","author":"M Unal","year":"2003","unstructured":"Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik Y. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol. 2003;123:1060\u20133. This report firstly showed the effect of intraturbinal injection of BTX-A in allergic rhinitis patients.","journal-title":"Acta Otolaryngol"},{"key":"636_CR26","first-page":"643","volume":"17","author":"J Wang","year":"2003","unstructured":"Wang J, Chen F, Meng M, Zhang X, Chen Y, Huang W, et al. The influence of botulinum toxin type A on vasomotor rhinitis and morphological study. [Article in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003;17:643\u20135.","journal-title":"Lin Chuang Er Bi Yan Hou Ke Za Zhi"},{"key":"636_CR27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.otohns.2008.06.031","volume":"139","author":"TY Yang","year":"2008","unstructured":"Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg. 2008;139:367\u201371.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"636_CR28","first-page":"45","volume":"46","author":"T Sapci","year":"2008","unstructured":"Sapci T, Yazici S, Evcimik MF, et al. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Rhinology. 2008;46:45\u201351.","journal-title":"Rhinology"},{"key":"636_CR29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0030-6657(11)70637-0","volume":"65","author":"K Nowak","year":"2011","unstructured":"Nowak K, Szyfter W. Application of botulinum toxin A in chronic intrinsic rhinitis. [Article in Polish]. Otolaryngol Pol. 2011;65:103\u20135.","journal-title":"Otolaryngol Pol"},{"key":"636_CR30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjoto.2011.01.004","volume":"33","author":"T Braun","year":"2012","unstructured":"Braun T, G\u00fcrkov R, Kramer MF, Krause E. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study. Am J Otolaryngol. 2012;33:64\u20137. This article showed the effect of nasal septal BTX-A injection in idiopathic rhinitis patients.","journal-title":"Am J Otolaryngol"},{"key":"636_CR31","first-page":"400","volume":"18","author":"SM Abtahi","year":"2013","unstructured":"Abtahi SM, Hashemi SM, Abtahi SM, Bastani B. Septal injection in comparison with inferior turbinates injection of botulinum toxin A in patients with allergic rhinitis. J Res Med Sci. 2013;18:400\u20134.","journal-title":"J Res Med Sci"},{"key":"636_CR32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2332\/allergolint.12-OA-0510","volume":"62","author":"SM Hashemi","year":"2013","unstructured":"Hashemi SM, Okhovat A, Amini S, Pourghasemian M. Comparing the effects of botulinum toxin-A and cetirizine on the treatment of allergic rhinitis. Allergol Int. 2013;62:245\u20139.","journal-title":"Allergol Int"},{"key":"636_CR33","first-page":"5","volume":"11","author":"H Shemshadi","year":"2013","unstructured":"Shemshadi H, Azimian M, Kamrani AAK, Onsori MA. Botulinum toxin type A on an intranasal sponge for chronic allergic rhinitis: randomized clinical trial. Iran Rehabil J. 2013;11:5\u201311.","journal-title":"Iran Rehabil J"},{"key":"636_CR34","first-page":"253","volume":"27","author":"K Mozafarinia","year":"2015","unstructured":"Mozafarinia K, Abna M, Khanjani N. Effect of botulinum neurotoxin A injection into the submucoperichondrium of the nasal septum in reducing idiopathic non-allergic rhinitis and persistent allergic rhinitis. Iran J Otorhinolaryngol. 2015;27:253\u20139.","journal-title":"Iran J Otorhinolaryngol"},{"key":"636_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11882-010-0089-z","volume":"10","author":"D Pattanaik","year":"2010","unstructured":"Pattanaik D, Lieberman P. Vasomotor rhinitis. Curr Allergy Asthma Rep. 2010;10:84\u201391.","journal-title":"Curr Allergy Asthma Rep"},{"key":"636_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2310\/7070.2006.0080","volume":"35","author":"Y Vayisoglu","year":"2006","unstructured":"Vayisoglu Y, Ozcan C, Pekdemir H, Gorur K, Pata YS, Camsari A. Autonomic nervous system evaluation using heart rate variability parameters in vasomotor rhinitis patients. J Otolaryngol. 2006;35:338\u201342.","journal-title":"J Otolaryngol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-016-0636-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-016-0636-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-016-0636-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:39:30Z","timestamp":1718714370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-016-0636-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s11882-016-0636-3","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"58"}}